We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 542

Pharmacy and hospital interests present comments on proposed compounding bill
  • Shook Hardy & Bacon LLP
  • USA
  • June 20 2013

Proposed legislation (S. 959) that would give the U.S. Food and Drug Administration (FDA) the authority to oversee compounding pharmacies that ship


SCOTUS sides with FTC in reverse payment deals
  • Shook Hardy & Bacon LLP
  • USA
  • June 20 2013

A divided U.S. Supreme Court has determined that patent-infringement settlement agreements requiring the patentee to pay the claimed infringer


Biotech set to raise $86 million in IPO to support cancer and IEM products
  • Shook Hardy & Bacon LLP
  • USA
  • June 20 2013

Agios Pharmaceuticals, Inc. has filed a registration statement with the U.S. Securities and Exchange Commission indicating its intent to raise up to


Neumedicines receives $8.3 million from BARDA for radiation sickness drug
  • Shook Hardy & Bacon LLP
  • USA
  • June 20 2013

Pasadena-based Neumedicines Inc. has reportedly received $8.3 million from the Biomedical Advanced Research & Development Authority (BARDA) of the U


U.S. Supreme Court issues ruling on patentability of human genes
  • Shook Hardy & Bacon LLP
  • USA
  • June 20 2013

The U.S. Supreme Court has determined that while human genes and the information they encode are not patent eligible, despite the effort required to


News Bytes - June 20, 2013
  • Shook Hardy & Bacon LLP
  • USA, Global
  • June 20 2013

The U.S. Patent and Trademark Office (USPTO) launches a joint pilot project with the Korean Intellectual Property Office (KIPO) which will classify


Biopharmaceutical companies have 215 heart diseasestroke drugs in R&D pipeline
  • Shook Hardy & Bacon LLP
  • USA
  • June 20 2013

According to a new Pharmaceutical Research and Manufacturers of America (PhRMA) report, U.S. biopharmaceutical companies have 215 medicines under


FDA seeks comments on de-identified and masked data
  • Shook Hardy & Bacon LLP
  • USA
  • June 20 2013

The U.S. Food and Drug Administration (FDA) has issued a notice seeking comments on "the proposed availability of de-identified and masked data


Researchers conclude costs of litigation growing in relation to benefits of patent protections
  • Shook Hardy & Bacon LLP
  • USA
  • June 20 2013

Economics, law and technology scholars affiliated with U.S. and German institutions have issued a paper that examines data on the costs of patent


En banc Federal Circuit issues ruling on appellate jurisdiction over patent infringement issues
  • Shook Hardy & Bacon LLP
  • USA
  • June 20 2013

The Federal Circuit Court of Appeals en banc has determined that parties may appeal the liability issues in a patent infringement action even if the